Trending Now
Yeti Holdings (NYSE:YETI) beats the market trend
With two straight days of severe market declines, it’s odd to see a symbol show some green on a watchlist. I like...
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Provides Updates Of Its 2020 Achievements And...
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) has highlighted is achievements in 2020 and offered a strategy that will help its realize considerable opportunity for...
Heron Therapeutics Inc. (NASDAQ:HRTX) Resubmits HTC-011 New Drug Application To The...
Heron Therapeutics Inc. (NASDAQ:HRTX) has announced the resubmission of the New Drug Application for HTX-011 to the US FDA. HTX-011 is an...
Popular News
Cure SMA and Cytokinetics, Inc. (NASDAQ:CYTK) Expands It Partnership to Intensify...
Cytokinetics, Inc. (NASDAQ:CYTK) has built a 20-year history of successful business operations through advanced research and innovation. The company has grown into being a...
MAKE IT MODERN
LATEST REVIEWS
Onconova Therapeutics Inc (NASDAQ:ONTX) Expects To Announce Topline Data Of Inspire...
Onconova Therapeutics Inc (NASDAQ:ONTX) anticipates reporting topline data by the end of Q3 2020 following it’s INSPIRE clinical study achieving all the survival points. IND...
MAKE IT MODERN
PERFORMANCE TRAINING
Incyte (NASDAQ:INCY) Enters Agreement With Nimble Therapeutics For the discovery of Peptide Therapies
Incyte (NASDAQ:INCY) has entered a strategic collaboration with Nimble Therapeutics Inc. for the discovery of first in class peptide therapies in different disease areas. Nimble...
SPY breaks through resistance at 331.66 to head higher
The market made a big move higher overnight, again and is currently sitting at 331.84 haveing just broken through resistance at 331.66....
Stocks to End the Opioid Epidemic (ECOR, PCRX, ENDV, NVCR)
Opioid drugs have done more damage over the last few years than Covid-19. But now, because of the pandemic, the opioid crisis has significantly...
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Enrols First Subject In COV-Logic Study Evaluating TNX-1800
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has announced the enrolment of the first patient in its observational COV-LOGIC (TNX-C001) study of cellular (T-cell) and humoral...
AIM ImmunoTech (NYSE:AMERICAN:AIM) Files Interim Patent Application For Using Ampligen To Treat SARS-CoV-2 Induced...
AIM ImmunoTech (NYSE:AMERICAN:AIM) has announced the filing of provisional patent application to use Ampligen as a possible early-onset therapy for COVID-19 induced CFS. The...
MAKE IT MODERN
[/tdc_zone]